hepatitis C

A New Fifty-Year-Old Hepatitis C Drug
Seeking Alpha
Sat, 04/11/15 - 10:18 am
hepatitis C
chlorcyclizine
Gilead: Little Hep C Competition, But What About Pricing?
Barron's
Fri, 04/10/15 - 03:50 pm
Gilead Sciences
Merck
AbbVie
hepatitis C
Gilead’s $1,000 Pill Is Hard for States to Swallow
WSJ Online
Wed, 04/8/15 - 05:32 pm
Gilead
hepatitis C
drug pricing
Harvoni
Sovaldi
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Merck
AbbVie
hepatitis C
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Merck's potential HCV drug gets special FDA designation
Yahoo/AP
Wed, 04/8/15 - 10:41 am
Merck
hepatitis C
FDA
grazoprevir/elbasvir
Gilead Q1 Hep C Sales Look Ahead Of Consensus
Barron's
Mon, 04/6/15 - 05:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?
Motley Fool
Wed, 04/1/15 - 08:45 am
Gilead Sciences
Achillion
hepatitis C
Sovaldi
Harvoni
Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
Motley Fool
Sun, 03/29/15 - 11:53 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie
Viekira Pak
Gilead Sciences: Harvoni Going Strong, Sovaldi Not So Much
Barron's
Fri, 03/27/15 - 12:01 pm
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Gilead Sciences: Big in Japan?
Barron's
Thu, 03/26/15 - 12:57 pm
Gilead Sciences
Japan
hepatitis C
Sovaldi
Which diseases are driving drug spending hikes? It's not just hep C
Fierce Pharma
Wed, 03/25/15 - 08:50 am
drug spending
hepatitis C
Gilead Warning of Hep C Patient Death on Heart Med Will Have “Zero Impact”
WSJ Pharmalot
Mon, 03/23/15 - 11:40 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead Warns After Hepatitis Patient on Heart Drug Dies
Yahoo/Bloomberg
Sun, 03/22/15 - 10:45 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Charity attacks Gilead over hepatitis C drug restrictions
Yahoo/Reuters
Wed, 03/18/15 - 08:06 pm
Gilead Sciences
Sovaldi
Harvoni
hepatitis C
developing countries
Gilead Sciences: How Big a Threat is Merck?
Barron's
Tue, 03/17/15 - 07:17 pm
Merck
Gilead Sciences
hepatitis C
Gilead's hepatitis C drugs largely cost-effective in U.S. -study
Yahoo/Reuters
Tue, 03/17/15 - 10:13 am
Gilead Sciences
hepatitis C
Sovaldi
AbbVie Inc Viekira Pak Prescription Volumes Climb, Gilead Sciences, Inc. Harvoni Falls
Bidness Etc.
Fri, 03/13/15 - 12:08 pm
AbbVie
Gilead Sciences
Harvoni
Viekira Pak
hepatitis C
FDA to review re-submitted Bristol-Myers hepatitis C drug
Yahoo/Reuters
Thu, 03/12/15 - 09:44 pm
FDA
Bristol-Myers Squibb
daclatasvir
hepatitis C
In Case You Missed It, Gilead Sciences, Inc.’s “Bad” News Is Actually Great
Motley Fool
Tue, 03/10/15 - 09:05 am
Gilead Sciences
hepatitis C
AbbVie
Viekira Pak
Sovaldi
Harvoni
Hepatitis Pills Spark Biggest Jump In Drug Costs In A Decade
Forbes
Tue, 03/10/15 - 08:18 am
drug spending
hepatitis C

Pages